Mydecine Innovations Group (OTCMKTS:MYCOF) Stock Price Down 3.8%

Mydecine Innovations Group Inc. (OTCMKTS:MYCOFGet Rating) fell 3.8% during mid-day trading on Tuesday . The company traded as low as $0.85 and last traded at $1.00. 1,215 shares changed hands during trading, a decline of 94% from the average session volume of 19,034 shares. The stock had previously closed at $1.04.

The stock has a fifty day simple moving average of $2.33 and a 200-day simple moving average of $5.35.

About Mydecine Innovations Group (OTCMKTS:MYCOF)

Mydecine Innovations Group Inc, a biotech and life sciences company, engages in the development and commercialization of drugs for treating mental health problems. It develops therapies for veterans, emergency medical service providers, post-traumatic stress disorder, and frontline workers, as well as provides digital health platform and therapeutics; and mental health solutions.

Recommended Stories

Receive News & Ratings for Mydecine Innovations Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mydecine Innovations Group and related companies with MarketBeat.com's FREE daily email newsletter.